Notre groupe organise plus de 3 000 séries de conférences Événements chaque année aux États-Unis, en Europe et en Europe. Asie avec le soutien de 1 000 autres Sociétés scientifiques et publie plus de 700 Open Access Revues qui contiennent plus de 50 000 personnalités éminentes, des scientifiques réputés en tant que membres du comité de rédaction.

Les revues en libre accès gagnent plus de lecteurs et de citations
700 revues et 15 000 000 de lecteurs Chaque revue attire plus de 25 000 lecteurs

Abstrait

From Heterogeneity to Hope: Uniting Efforts in Atherosclerosis Research and Therapeutic Development

James David

The utilization of single cell technologies, lineage tracing mouse models, and advanced imaging techniques has significantly enhanced our understanding of the cellular landscape of atherosclerosis. These advancements have provided a clearer resolution of the diverse cellular states involved in the progression of atherosclerosis. However, this increased knowledge has also introduced greater complexity to current and future research, requiring a reevaluation of our approach to drug development. This review explores the impact of recent advancements in single cell technologies, which have allowed us to map the intricate cellular networks within atherosclerotic plaques. Additionally, we address the existing technological limitations that hinder our ability to identify the key cellular drivers of the disease and identify specific cell states, subsets, or surface antigens as potential drug targets for atherosclerosis.